These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 9489814

  • 1. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis.
    Rahman P, Humphrey-Murto S, Gladman DD, Urowitz MB.
    J Rheumatol; 1998 Feb; 25(2):243-6. PubMed ID: 9489814
    [Abstract] [Full Text] [Related]

  • 2. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
    Carneiro JR, Sato EI.
    J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
    [Abstract] [Full Text] [Related]

  • 3. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V.
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate in nonrenal lupus and undifferentiated connective tissue disease--a review of 36 patients.
    Wise CM, Vuyyuru S, Roberts WN.
    J Rheumatol; 1996 Jun; 23(6):1005-10. PubMed ID: 8782131
    [Abstract] [Full Text] [Related]

  • 5. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
    Khanna D, Park GS, Paulus HE, Simpson KM, Elashoff D, Cohen SB, Emery P, Dorrier C, Furst DE.
    Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
    [Abstract] [Full Text] [Related]

  • 6. Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus.
    Rahman P, Gladman DD, Urowitz MB.
    J Rheumatol; 1998 Sep; 25(9):1716-9. PubMed ID: 9733451
    [Abstract] [Full Text] [Related]

  • 7. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
    Wenzel J, Brähler S, Bauer R, Bieber T, Tüting T.
    Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus.
    Islam MN, Hossain M, Haq SA, Alam MN, Ten Klooster PM, Rasker JJ.
    Int J Rheum Dis; 2012 Feb; 15(1):62-8. PubMed ID: 22324948
    [Abstract] [Full Text] [Related]

  • 10. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R, Schleusser B, Herborn G, Karger T.
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [Abstract] [Full Text] [Related]

  • 11. Methotrexate in systemic lupus erythematosus.
    Walz LeBlanc BA, Dagenais P, Urowitz MB, Gladman DD.
    J Rheumatol; 1994 May; 21(5):836-8. PubMed ID: 8064722
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus.
    Ravelli A, Ballardini G, Viola S, Villa I, Ruperto N, Martini A.
    J Rheumatol; 1998 Mar; 25(3):572-5. PubMed ID: 9517783
    [Abstract] [Full Text] [Related]

  • 13. Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.
    Kremer JM, Habros JS, Kolba KS, Kaine JL, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisemandle W, Mekki QA, Tacrolimus-Methotrexate Rheumatoid Arthritis Study Group.
    Arthritis Rheum; 2003 Oct; 48(10):2763-8. PubMed ID: 14558080
    [Abstract] [Full Text] [Related]

  • 14. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators.
    Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
    [Abstract] [Full Text] [Related]

  • 15. Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
    Fortin PR, Abrahamowicz M, Ferland D, Lacaille D, Smith CD, Zummer M, Canadian Network For Improved Outcomes in Systemic Lupus.
    Arthritis Rheum; 2008 Dec 15; 59(12):1796-804. PubMed ID: 19035431
    [Abstract] [Full Text] [Related]

  • 16. A 2 year, open ended trial of methotrexate in systemic lupus erythematosus.
    Wilson K, Abeles M.
    J Rheumatol; 1994 Sep 15; 21(9):1674-7. PubMed ID: 7799348
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
    Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, Antoni C, Leeb B, Elliott MJ, Woody JN, Schaible TF, Feldmann M.
    Arthritis Rheum; 1998 Sep 15; 41(9):1552-63. PubMed ID: 9751087
    [Abstract] [Full Text] [Related]

  • 18. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
    Luis M, Pacheco-Tena C, Cazarín-Barrientos J, Lino-Pérez L, Goycochea MV, Vazquez-Mellado J, Burgos-Vargas R.
    Arthritis Rheum; 1999 Oct 15; 42(10):2160-5. PubMed ID: 10524688
    [Abstract] [Full Text] [Related]

  • 19. [Therapeutic maintenance level of methotrexate in rheumatoid arthritis].
    Tahiri L, Allali F, Jroundi I, Abouqal R, Hajjaj-Hassouni N.
    Sante; 2006 Oct 15; 16(3):167-72. PubMed ID: 17284392
    [Abstract] [Full Text] [Related]

  • 20. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis.
    Woo P, Southwood TR, Prieur AM, Doré CJ, Grainger J, David J, Ryder C, Hasson N, Hall A, Lemelle I.
    Arthritis Rheum; 2000 Aug 15; 43(8):1849-57. PubMed ID: 10943876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.